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Manipulatable models of bladder development which interrogate specific pathways are badly needed. Such models will allow a systematic
investigation of the multitude of pathologies which result from developmental defects of the urinary bladder. In the present communication, we
describe a model in which mouse embryonic stem (ES) cells are directed to differentiate to form bladder tissue by specific interactions with fetal
bladder mesenchyme. This model allows us to visualize the various stages in the differentiation of urothelium from ES cells, including the
commitment to an endodermal cell lineage, with the temporal profile characterized by examining the induction of specific endodermal
transcription factors (Foxa1 and Foxa2). In addition, final functional urothelial differentiation was characterized by examining uroplakin
expression. It is well established that ES cells will spontaneously develop teratomas when grown within immunocompromised mouse hosts. We
determined the specific mesenchymal to ES cell ratios necessary to dictate organ-specific differentiation while completely suppressing
teratomatous growth. Embryonic mesenchyme is well established as an inductive tissue which dictates organ-specific programming of epithelial
tissues. The present study demonstrates that embryonic bladder mesenchyme can also steer ES cells towards developing specific endodermal
derived urothelium. These approaches allow us to capture specific stages of stem cell differentiation and to better define stem cell hierarchies.
© 2007 Elsevier Inc. All rights reserved.Keywords: Embryonic stem cells; Urothelium; Bladder; Embryonic mesenchyme; Endoderm; Bladder progenitor cell; Directed differentiationIntroduction
To elucidate the control of normal and abnormal bladder
development, a model is needed that will allow the investigation
from embryogenesis through adult differentiation. MultipleAbbreviations: ES, embryonic stem cells; EBLM, embryonic bladder
mesenchyme; SMA, smooth muscle α-actin; E16, embryonic day 16; LCM,
laser capture microdissection; NeuN, neuronal nuclear antigen A60; UGM,
urogenital mesenchyme; PCR, polymerase chain reaction.
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doi:10.1016/j.ydbio.2007.01.010congenital disease states affect the bladder, including posterior
urethral valves, bladder/cloacal exstrophy, and myelomeningo-
cele. In order to better understand these conditions, we
developed a model using embryonic stem (ES) cells and tissue
recombination. The model described follows the temporal–
spatial events involved in bladder development and captures
early protein expression patterns that have not previously been
studied. These proteins may be unique to bladder stem and/or
progenitor cells and could assist with their cellular isolation and
characterization.
Instead of attempting to work from a mature bladder
backwards to identify bladder stem and/or progenitor cells, we
proposed starting from pluripotent ES cells which could be
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embryonic bladder mesenchyme (EBLM) to potentially direct
formation of bladder tissues. Tissue recombination has led to a
better understanding of bladder biology, especially with the
premise that the mesenchyme is required to direct epithelial
differentiation (Baskin et al., 1996a; Baskin et al., 1996b;
DiSandro et al., 1998; Liu et al., 2000). We hypothesized that
EBLM could dictate the differentiation of mouse ES cells into
the endodermally derived bladder urothelial lineage. Undir-
ected, grafted ES cells will form teratomas (Bradley et al.,
1984; Gertow et al., 2004; Heins et al., 2004; Przyborski et al.,
2004; Reubinoff et al., 2000; Thomson et al., 1998). This
approach elucidates the process of bladder development and
also offers the ability to identify bladder progenitor cells.
Using ES cells in this approach, it is possible to generate other
organs that require mesenchymal signals to differentiate
(Taylor et al., 2006). Therefore, it should be possible to
follow ES cell differentiation into germ layer restricted
progenitor cells that give rise to the fully mature organ. The
characterization of these cell types is important with the
potential applications for regenerative medicine and organ
rehabilitation in disease states.
Materials and methods
Tissue culture of mouse embryonic stem cells
Mouse ES cells (PluriStem B6-White; Chemicon International, Temecula,
CA) were grown on a mitotically inactivated primary mouse embryonic
fibroblast feeder layer in Iscove’s modified Dulbecco’s medium with 4 mM L-
glutamine and HEPES (IMDM; Hyclone, Logan, UT) supplemented with 20%
FCS (ES cell qualified, Hyclone), 0.1 mM non-essential amino acids (Hyclone),
1 mM sodium pyruvate (Hyclone), 0.1 mM 2-mercaptoethanol (Sigma, St.
Louis, MO), 100 U/ml penicillin (Sigma) and 100 U/ml streptomycin (Sigma),
and 1000 U/ml leukemia inhibitory factor (ESGRO; Chemicon International).
The medium was changed daily.
Tissue recombination grafts of mouse embryonic stem cells with rat
embryonic bladder mesenchyme
All animal experiments were performed in accordance with the Institutional
Animal Care and Use Committee at Vanderbilt University. Pregnant Sprague–
Dawley rats (Harlan, Indianapolis, IN) were sacrificed at embryonic day 18
(plug day=0). The embryos were isolated and bladders removed. The bladders
were separated from the urogenital sinus at the bladder neck prior to separation
in Hanks/EDTA. The epithelial and mesenchymal components were micro-
dissected, isolated, then washed thoroughly in RPMI-1640 (Gibco, Grand
Island, NY) and stored in medium prior to use. ES cells were detached from their
flasks by gentle trypsinization and viable cells counted on a hemocytometer
using trypan blue exclusion. ES cells (50–1500 cells) were re-suspended in
40 μl of rat collagen matrix and plated as a plug. This plug formed a half-oval
like structure measuring 3 mm in widest diameter and 2 mm in height. EBLM,
now left as pure mesenchymal shells devoid of epithelium (1 or 4 shells utilized
per graft depending on the experimental condition) were physically placed into
each collagen plug and then incubated at 37 °C for plug solidification. Prior to
grafting, each mesenchymal shell measured approximately 0.4 mm×0.4 mm in
size, therefore no difficulty was encountered when placing the shell(s) into the
collagen plugs. Tissue culture media (RPMI-1640; [Gibco]) supplemented with
1% antibiotic–antimycotic solution (Gibco), 5% cosmic calf serum (CCS)
(Hyclone) was then applied for 1 h.
To obtain approximate cell numbers contained within individual EBLM
shells, collagenase separation was performed. EBLMwas reduced to single cells
by a 90-min digestion at 37 °C with 187 U/ml collagenase-lyophilized (Gibco,cat. #17018-029) in RPMI-1640 tissue culture medium containing 10% fetal
bovine serum (Atlanta Biologicals, Lawrence, GA). Following digestion, the
cells were washed extensively with RPMI-1640 tissue culture medium to
remove traces of collagenase. Viable cells were then counted using a
hemocytometer with trypan blue exclusion.
Athymic nude mouse host xenografting
Male athymic nude mice (CD-1 nu/nu Charles River) aged 7–8 weeks were
hosts for sub-renal capsule grafts. A 1-cm vertical skin incision along the dorsal
midline was made and the kidney was introduced with gentle pressure. A
capsulotomywas made in the kidney and a subcapsular space was created. Grafts
were then placed underneath the renal capsule and maneuvered into various
locations along the kidney. Two grafts were placed into each kidney which was
then reintroduced back into themouse. Surgical incisions were closedwith suture
and staples.
Xenograft harvest and processing
Hosts were sacrificed at 7, 14, and 42 days post grafting. Mice were
sacrificed by anesthetic overdose followed by cervical dislocation. Grafts were
harvested and the kidneys removed en-bloc. Whole kidneys were placed in 10%
neutral buffered formalin for 24 h. After fixation, grafts were trimmed leaving a
margin of renal parenchyma to aid in graft orientation. Specimens were
processed, paraffin embedded, and sections cut at 5 μm for staining and
immunohistochemistry (IHC).
In addition, normal mouse tissues were examined and served as controls
which included: embryonic day 16 (E16), postnatal day 1, and adult (6 months
of age) mouse bladders. Tissues were processed and embedded in the same
fashion as the xenografts, then cut in 5-μm sections for staining and IHC.
Staining and Immunohistochemistry
Sections for Gomori’s trichrome staining were carried out with Gomori’s
One-Step Green Trichrome Stain System (DakoCytomation) and an automated
stainer platform. This staining was performed by the Vanderbilt mouse histology
core facility.
For IHC, all incubations were carried out at room temperature unless
otherwise stated. Slides were deparaffinized and hydrated through xylene and
graded alcohols. Antigen retrieval was performed on slides stained for Foxa1,
Foxa2, p63, and Neun and achieved with microwaving in 1% antigen
unmasking solution (Vector laboratories, Burlingame, CA) for 20 min, then left
at room temperature for 1 h. Endogenous peroxidase activity was blocked with
DAKO Peroxidase Blocking Reagent (DAKO Corp., Carpinteria, CA) for
15 min and sections were washed in PBS for 5 min. IHC was performed using
the Vectastatin Elite ABC peroxidase kit (Vector Laboratories) according to the
manufacturer’s protocol. Briefly, non-specific antibody binding was minimized
by incubating sections for 20 min in diluted normal blocking serum. Sections
were incubated overnight at 4 °C in a humidified chamber with primary
antibodies, at indicated dilutions were: broad-spectrum uroplakin (rabbit,
1:1000; a generous gift from Dr. TT Sun, New York University), smooth
muscle α-actin (mouse, 1:1000; Sigma), p63 (rabbit, 1:200; Santa Cruz
Biotechnology, Santa Cruz, CA), Foxa1 (goat, 1:1000; Santa Cruz), Foxa2
(goat, 1:1000; Santa Cruz), and neuronal nuclear antigen A60 (NeuN) (mouse,
1:100; Abcam, Cambridge, MA). Following overnight incubation, slides were
washed in PBS for 5 min. Sections were then incubated for 30 min with
biotinylated secondary antibody solution diluted in PBS, followed by
Vectastatin Elite ABC Reagent diluted in PBS for 30 min. Between in-
cubations, sections were washed for 5 min in PBS. Visualization of
immunoreactivity was achieved by incubating sections in either DAKO Liquid
DAB Substrate-Chromogen System (DAKO Corp.) for 2–4 min or the DAB
peroxidase substrate kit (Vector Laboratories) for 10 min. The sections were
washed in double distilled H2O, counterstained with hematoxylin, dehydrated,
and cover slipped. Negative controls were set up at the same time as the
primary antibody incubations and included incubation with PBS, in place of
the primary antibody. No immunoreactivity was observed in these negative
control sections.
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reaction
Tissue for laser capture microdissection (LCM) was collected prospectively
following tissue processing and paraffin wax embedding. Approximately 1500
cells were microdissected from both urothelial compartments of the 42-day
recombinant grafts using a Pix Cell II laser capture microscope (Arcturus, CA).
As controls, tissue was also microdissected from native adult mouse and adult
rat bladder tissue. DNA was extracted in lysis buffer containing 0.04%
proteinase K (New England BioLabs, Inc., Ipswich, MA), 10 mM Tris–HCl pH
8.0 (EM Science, Gibbstown, NJ), 1 mM EDTA (Sigma), 1% Tween 20 (EM
Science). Tissues were incubated in 50 μl of lysis buffer overnight at 37 °C, then
boiled at 98 °C for 8 min to degrade the proteinase K.
Total DNA was utilized for PCR utilizing mouse and rat species-specific
primers encoding for the probasin gene (mouse probasin gene product 302 bp,
rat probasin gene product 420 bp). Mouse primers consisted of the following
forward and reverse sequences: 5′-TCACATTTTGTGTGGGAGGA-3′ (for-
ward) and 5′-CATATAATCACAACCCATCTCTTGA-3′ (reverse). Rat primers
consisted of: 5′-TTGAAGGGAATTGGAGAACC-3′ (forward) and 5′-
CATCCCTCCAGCCCTATCTA-3′ (reverse). PCR reactions were performed
with Taq DNA polymerase (Sigma) in 25 μl reactions under the following
scheme: 94 °C for 5 min, then 30 cycles (94 °C for 45 s, 58 °C for 45 s, 68 °C
for 90 s), then 68 °C for 5 min. Final DNA products were detected on a 2%
agarose gel.Results
Bladder development from embryonic stem cells
Initial experiments were carried out with ES cells alone,
without EBLM, to identify the number of ES cells necessary perFig. 1. Xenografts harvested at 42 days. (a) Gross appearance of 1000 embryonic stem
(b–d) Histology and immunohistochemical staining of 1000 ES cell+1 embryonic bl
central lumen of bladder structure, urothelial cells surrounding central lumen (red) w
detection of broad-spectrum uroplakin (brown) denoting mature urothelium. (d) Imm
muscle fibrils.graft to yield teratoma formation. Eight grafts (2 for each
condition) were created by titrating numbers of ES cells as
follows: 50, 100, 500, and 1000. Grafts were harvested at 42
days post in vivo incubation. Grossly, grafts measured 3–
10 mm in diameter, with smaller grafts (3–4 mm in diameter)
observed at 50, 100, 500 ES cells and large tumors (7–10 mm in
diameter) seen at 1000 cells (Fig. 1a). Consistent with an
expectation of benign histology no gross invasion outside of the
renal capsule or into the renal parenchyma was observed. H&E
staining of the ES cell alone grafts at 50, 100, 500 cells revealed
no significant growth or patterns of differentiation (data not
shown). One thousand ES cells per graft yielded multiple well-
differentiated structures forming teratomas, consistent with
previous findings in the literature (Bradley et al., 1984; Gertow
et al., 2004; Heins et al., 2004; Przyborski et al., 2004;
Reubinoff et al., 2000; Thomson et al., 1998). Within the
teratomas, tissue types from all 3 embryonic germ cell layers
were present including the cartilage, brain, skeletal muscle,
neural structures, pancreatic, and intestinal tissue (Supplemen-
tary Figs. 8a–d). No evidence of spontaneous bladder tissue
formation occurred in these ES cell derived teratomas, verified
by negative uroplakin detection, a highly sensitive and specific
marker for mature urothelium.
Next, 1 EBLM shell per graft (equivalent of 300,000
mesenchymal cells post collagenase separation) were recom-
bined with titrating numbers of ES cells as follows: 50, 100,
500, and 1000 (n=8), then harvested after 42 days of
incubation. Grossly, the tissue recombinants with the 50, 100,(ES) cell grafts on host kidney (arrowheads denote whitish-tan appearing grafts).
adder mesenchyme shell recombinant graft. (b) Gomori's trichrome, star denotes
ith sub-urothelial connective tissue (blue) were seen. (c) Immunohistochemical
unohistochemical detection of smooth muscle α-actin (brown) denoting smooth
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a paucity of growth with no evidence of bladder tissue
formation. The 1000 ES cell recombinants were grossly larger
in size measuring 7–10 mm in diameter and yielded multiple
well-differentiated structures forming as a teratoma, however, a
small population of tissues resembled bladder structures (Fig.
1b). These structures had central lumenoid cavities, a cluster of
surrounding multilayered epithelium, a sub-epithelial connec-
tive tissue layer consistent with lamina propria-like tissue, and
smooth muscle fibrils. Immunolocalization of uroplakin
verified mature bladder urothelial differentiation and was
associated with the epithelial lining of the lumenoid structures
(Fig. 1c). Fig. 1d demonstrates smooth muscle α-actin (SMA)
immunolocalization, indicating smooth muscle cell develop-
ment, respectively surrounding mature urothelium. Overall,
cellular organization and immunohistochemical staining was
consistent with normal bladder tissue histology. These findings
demonstrated that ES cells, under the inductive signalingFig. 2. Xenografts of 1500 embryonic stem cells+4 embryonic bladder mesenchy
cuboidal urothelial cells (red) with sub-urothelial connective tissue (blue) were seen. (
smooth muscle fibrils. (e, f) Immunohistochemical detection of broad-spectrum uropenvironment provided by EBLM, could undergo complex
differentiation along an endodermal lineage to form mature
urothelium with bladder tissue formation.
Since 1000 ES cells+1 EBLM shell per graft were sufficient
to form a small population of bladder tissues within a teratoma,
we created recombinants which consisted of 1500 ES cells+4
EBLM shells per graft in an attempt to further force the ES cells
to form the bladder phenotype. Since we significantly increased
the amount of EBLM per graft, the number of ES cells was
increased to 1500 in order to optimize mesenchymal–ES cell
interactions. A total of 4 recombinants were created and again
harvested after 42 days of incubation. Grossly, the recombinants
were smaller in size ranging from 2 to 3 mm in diameter.
Gomori’s trichrome staining of sections of all 4 recombinant
grafts demonstrated 100% bladder structures in each graft and
all grafts exhibited no evidence of teratoma formation (Figs. 2a,
b; see Supplementary Figs. 9a–d for low power images). Only
pure bladder tissue formation was observed, with absolutely nomal shells/graft harvested at 42 days. (a, b) Gomori's trichrome, multilayered
c, d) Immunohistochemical detection of smooth muscle α-actin (brown) denoting
lakin (brown) denoting mature urothelium.
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derived bladder tissue. In addition, trichrome staining demon-
strated a sub-epithelial connective tissue layer surrounding the
urothelium, consistent with lamina propria-like tissue in
combination with an outer smooth muscle layer as indicated
by SMA immunolocalization (Figs. 2c, d). Uroplakin expres-
sion by the epithelia demonstrated mature urothelial differentia-
tion and confirmed the bladder phenotype (Figs. 2e, f).
To better characterize the extent of bladder tissue
development in the 1500 ES+4 EBLM shells per graft
recombinants, markers identifying endoderm were examined.
The endodermal marker, Foxa1, was expressed in all of the
recombinant urothelial cells (Fig. 3c). Organization of the
recombinant urothelia was illustrated by using the basal cell
marker, p63 (Fig. 3b). Immunohistochemical detection of
p63-positive cells localized to the basilar urothelium only,Fig. 3. Xenografts of 1500 embryonic stem (ES) cells+4 embryonic bladde
Immunohistochemical detection of p63 (brown) illustrating complete spatial orientat
(brown) seen in all ES cell derived urothelium. (d) Immunohistochemical detection o
and immunohistochemical detection of neuronal nuclear antigen A60 (NeuN) (brown
Scale bars of 20 μm apply to images a–d. Scale bars of 10 μm apply to images e–fwith a marked lack of staining in the more central luminal
urothelial cells.
As controls, grafts of 1 EBLM shell alone (n=10) and 4
EBLM shells alone (n=4) were performed and harvested after
42 days of incubation. H&E and Gomori’s trichrome staining of
the EBLM only grafts demonstrated a paucity of growth with no
evidence of complex differentiation or bladder tissue formation
(data not shown). These findings were consistent with data
previously reported in the literature (Baskin et al., 1996a;
Oottamasathien et al., 2006).
Identification of bladder-specific stem and/or progenitor cells
In order to determine at what time period the ES cells
begin to undergo an endodermal cell lineage transformation,
experiments were performed to harvest recombinants at earlierr mesenchymal shells/graft harvested at 42 days. (a) H&E staining. (b)
ion of ES cell derived urothelium. (c) Immunohistochemical detection of Foxa1
f Foxa2 (brown) seen strongly positive in only a few urothelial cells. (e, f) H&E
) confirming the presence of neuronal cells clustering in the form of a ganglion.
.
561S. Oottamasathien et al. / Developmental Biology 304 (2007) 556–566incubation periods. Recombinants of 1500 ES cells+4 EBLM
shells were grafted, then harvested at 7- and 14-day time
points (n=6). Gomori’s trichrome staining revealed the
beginnings of cellular organization into bladder-like struc-
tures, yet the cells that looked destined to become urotheliumFig. 4. Xenografts of 1500 embryonic stem cells+4 embryonic bladder mesenchym
trichrome, cellular organization occurring in cells that look destined to become uroth
lack of expression within 7-day tissues and early expression observed in 14 day tissue
cells. (g, h) Immunohistochemical detection of Foxa2 (brown) denoting endodermalstill had significant disorder with mostly dysmorphic
morphology (Figs. 4a, b). Uroplakin staining was performed
on both the 7- and 14-day recombinant tissues but remained
undetectable at this stage of development consistent with the
lack of mature urothelium.al shells/graft harvested at 7 (a, c, e, g) and 14 (b, d, f, h) days. (a, b) Gomori's
elium (blue). (c, d) Immunohistochemical detection of p63 (brown) illustrating
s. (e, f) Immunohistochemical detection of Foxa1 (brown) denoting endodermal
cells.
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recombinant tissues, was undetectable in the 7-day tissues but
began to occur in a small cohort of cells after 14 days of
incubation (Figs. 4c, d). As previously identified, ES cells
converted to urothelium had gained complete spatial orientation
in the 42-day recombinant tissues, based on the basal expression
of p63 (Fig. 3b). This illustrated a temporal relationship for p63
expression in basal cells of endodermal tissue, with the
detection of endodermal markers preceding the ability to obtain
orientation properties.
In the early developing prostate, Foxa2 is initially expressed
in early embryonic developing glands, along with Foxa1. After
birth, Foxa2 becomes undetectable and Foxa1 continues to be
expressed in the mature ductal prostatic epithelium through
adulthood (Gao et al., 2005). Since the prostate and bladder are
both hindgut derivatives, the Fox family of proteins were
chosen as endodermal target proteins of interest. In the
recombinant time point grafts, both Foxa1 and Foxa2 were
detected in the 7-day tissues (Figs. 4e, g). By day 14, both Fox
proteins were abundant (Figs. 4f, h). As stated previously,
Foxa1 was detected in all of the urothelial cells in the 42-day
recombinants but interestingly, Foxa2 became almost extin-
guished in most cells and was intensely detectable in only a few
cells (Fig. 3d).
In order to establish baseline protein expression patterns in
normal mouse tissues, embryonic day 16 (E16), postnatal day
1, and adult mouse bladders were subjected to IHC staining
for broad-spectrum uroplakin, p63, Foxa1, and Foxa2 (Figs.Fig. 5. Native embryonic day 16 mouse bladder. (a) Immunohistochemical dete
Immunohistochemical detection of p63 (brown) demonstrating urothelial basilar o
urothelial cells denoting endodermal derivation of the cells. (d) Immunohistochemica
section.5–7). Fig. 5 shows that E16 mouse bladders fully express
uroplakin, have p63-positive basal urothelium, Foxa1 expres-
sion in all urothelial cells, and scant Foxa2 expression. Figs. 6
and 7 illustrate that postnatal day 1 and adult mouse bladders
share a similar profile, paralleling those observed in the E16
mouse bladders except Foxa2 was completely undetectable.
Laser capture microdissection/DNA isolation/polymerase
chain reaction
To further verify that the recombinant urothelium within the
42-day grafts was of mouse origin, LCM was utilized to obtain
tissue from various compartments. DNA samples were isolated
from the recombinant urothelium, native adult mouse bladders
(control), and native adult rat bladders (control). Polymerase
chain reaction (PCR) was performed with mouse and rat
specific primers for the probasin gene. Supplementary Fig. 10
illustrates the analysis of the mouse and rat probasin gene PCR
products. This confirmed the mouse origin of the recombinant
urothelium, yielding the 302-bp mouse probasin product. In
summary, LCM coupled with DNA isolation and PCR was
conclusive in defining the recombinant urothelial compartment
as having originated from the mouse ES cells and not from
potential rat urothelial contaminating elements in the EBLM
preparation. As previously described, none of the EBLM alone
grafts yielded bladder tissue growth, further substantiating that
the EBLM preparations utilized were devoid of urothelial
contaminants.ction of broad-spectrum uroplakin (brown) denoting mature urothelium. (b)
rientation. (c) Immunohistochemical detection of Foxa1 (brown) seen in all
l detection of Foxa2 (brown), arrow denotes one positive staining cell within the
Fig. 6. Native postnatal day 1 of life mouse bladder. (a) Immunohistochemical detection of broad-spectrum uroplakin (brown) denoting mature urothelium. (b)
Immunohistochemical detection of p63 (brown) demonstrating urothelial basilar orientation. (c) Immunohistochemical detection of Foxa1 (brown) seen in all
urothelial cells denoting endodermal derivation of the cells. (d) Complete lack of immunohistochemical detection of Foxa2.
Fig. 7. Native adult mouse bladder. (a) Immunohistochemical detection of broad-spectrum uroplakin (brown) denoting mature urothelium. (b) Immunohistochemical
detection of p63 (brown) demonstrating urothelial basilar orientation. (c) Immunohistochemical detection of Foxa1 (brown) seen in all urothelial cells denoting
endodermal derivation of the cells. (d) Complete lack of immunohistochemical detection of Foxa2.
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recombinants
In the H&E stains of some sections, neuronal cell clusters
formed having unique characteristics consistent with ganglionic
tissue. Immunohistochemical detection for neuronal nuclear
antigen A60 (NeuN) confirmed the neuronal nature of these cell
clusters (Figs. 3e, f). NeuN staining was also seen in individual
cells interlaced within the smooth muscle layers. The NeuN
antibody utilized was also tested on native mouse bladders
(E16, postnatal day 1 and adult) and adult rat bladders. Positive
staining was observed in only mouse tissue, with a complete
lack of detection in the rat tissue, verifying species specificity of
this antibody (data not shown). This illustrated that the neuronal
cells present within the recombinants either originated from the
ES cells or host mouse kidney, but they could not have arisen
from the rat EBLM constituents.
Discussion
In 1981, ES cells were isolated for the first time from mice.
This major break through, revolutionized the field of develop-
mental biology (Martin, 1981). ES cells can undergo prolonged
self-renewal and differentiation, thus providing a tool to
investigate the molecular mechanisms occurring during differ-
entiation from the embryonic stage to the adult phenotype. These
cells are considered to be pluripotent and can differentiate into
almost all cells that arise from the three embryonic germ layers
(Alison et al., 2002). In addition, ES cells can differentiate into
multiple embryonic and adult cell type’s in vitro, but rarely cells
of endodermal lineage (Trounson, 2006). Differentiation in an in
vivo environment yields the full developmental potential of
undifferentiated ES cell lines. For example, ES cells injected into
severe combined immunodeficient (SCID) mice formed benign
teratomas (Bradley et al., 1984; Gertow et al., 2004; Heins et al.,
2004; Przyborski et al., 2004; Reubinoff et al., 2000; Thomson et
al., 1998). In the ES cell teratomas, advanced differentiated
structures from all three embryonic germ cell (EG) layers were
present, including smooth muscle, bone, cartilage, gut, respira-
tory epithelium, keratinizing squamous epithelium, hair, neural
epithelium, and ganglia.
The presence of stem and/or progenitor cells within the
bladder is unknown, but hypothetically should exist. To identify
stem cells within the vast population of cells in the bladder
would be challenging, especially without bladder-specific stem/
progenitor cell markers. In attempt to identify bladder stem
cells, we forced ES cells to differentiate into bladder structures
rather than a teratoma. Thus, we document a transition of the ES
cells to early endoderm and then to the progenitor cells that give
rise to bladder stem cells and thence urothelium. Rather than
isolating a stem cell, we were watching it develop.
We hypothesized that if we can harness ES cells to produce
other organs rather than teratomas, we will have a unique
opportunity to investigate the molecular pathways that
determine the stem cells for multiple organs during embryonic
development. In order to study these pathways, it is important to
achieve almost 100% conversion of the ES cell to only onetissue type. Recently Taylor et al. (2006) reported that human
embryonic stem cells recombined with rat urogenital mesench-
yme (UGM) gave rise to immature and mature human prostate
tissue, supporting the hypothesis that specific organ tissues can
be influenced by inductive mesenchyme to form from ES cells.
Although, the precise inductive events regulating embryonic
pattern formation are still unknown; it is known that UGM
isolated from embryonic day 18 urogenital sinus can induce
freshly isolated adult bladder urothelium to develop a prostate
(Aboseif et al., 1999; Donjacour and Cunha, 1993; Neubauer et
al., 1983) and that the UGM is required for prostate
development (Cunha, 1972). Although this inductive nature of
UGM is well established, it is unknown whether the bladder
urothelium undergoes a trans-differentiation to prostatic
epithelium or if bladder and prostate share a common stem
cell that is controlled by different inductive mesenchyme.
Initial experiments showed that no significant growth and
differentiation into teratomas occurred at less than 500 ES cells
per graft. At 1000 cells per graft, complex structures
representing a teratoma occurred. Staining for a urothelial
marker, uroplakin, confirmed the lack of bladder tissues
spontaneously developing. Although theoretically ES cells
could generate urothelium and bladder tissues within a
teratoma, it was important to determine the minimum number
of ES cells needed to form a teratoma with the goal of
redirecting these ES cells to form only one organ type.
Based upon the findings that 1000 ES cells+1 EBLM shell
per graft yielded small foci of uroplakin expressing bladder
tissue within a teratoma, we hypothesized that the system could
be pushed further to form only pure bladder tissue devoid of
teratomatous elements by simply increasing the ratio of EBLM
to ES cells. We empirically increased both the number of
EBLM shells from one to four in each graft, along with
optimizing the number of ES cells from 1000 to 1500. This
ratio proved to be successful, the recombinants no longer
exhibited teratoma structures, only pure uroplakin expressing
urothelium with mature bladder tissues. Amazingly, the ES
cells conversion into mature urothelium exhibited cellular
organization that was complex such that the basilar located
cells were p63-positive and the central luminal urothelium
remained p63 negative. Within the recombinant stromal
compartment, smooth muscle layers correctly differentiated
and neuronal cells organized to form ganglionic tissue.
Additional neuronal cells were also present interlaced among
smooth muscle fibrils. These neuronal elements most likely
originated from the ES cells but we cannot rule out the host
kidney as the source. Clearly, the neuronal cells did not develop
from the rat EBLM since we confirmed the mouse species
specificity of these cells with the NeuN antibody. No other
reports have shown that neuronal elements would develop in
bladder tissue following a recombination of bladder urothelium
with bladder mesenchyme. Remarkably, the conversion of ES
cells to the bladder phenotype exhibited all the cellular
organization required for a functional bladder.
Embryonic bladders can only be readily identified around 14
days of gestation in the mouse. Therefore, the earlier events that
orchestrate endodermal lineage differentiation have been
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recombinant tissues reflects stages of ES cells conversion into
endoderm, then from endoderm to bladder stem cells, then from
stem cells to mature urothelium within bladder tissue. Further
studies will be needed to follow their complete developmental
progression.
No studies or models to date have described endodermal
lineage protein expression patterns in the developing bladder to
adult maturation. In our time point experiments, we first
detected the endodermal markers of Foxa1 and Foxa2 at 7 days,
then extensively by 14 days. During these stages, uroplakin was
undetectable, consistent with studies that have shown that
immature urothelium does not express uroplakin (Lavelle et al.,
2002; Romih et al., 1998). Although these cells were
endodermal and looked destined to become urothelium, they
were not mature urothelium at these two early time points.
Since little is known about the gene expression patterns in
the developing bladder, we based our experimental parameters
on what is known in the prostate since both organs are hindgut
derivatives. Mirosevich et al. (2005) reported that embryonic
day 18 rodent prostate and bladders express Foxa1 in the
epithelial compartments and Besnard et al. (2004) identified
Foxa1 expression in the urothelium of adult bladders. It is
known that Foxa2 expression in the developing prostate occurs
in very early epithelial budding during embryogenesis and that
its expression coincides with Foxa1 expression (Mirosevich et
al., 2005). As the developing prostate forms more mature
glands, Foxa1 expression is retained in the epithelium through
adulthood and Foxa2 is extinguished postnatally. Our findings
parallel those in the prostate, Foxa1 and Foxa2 expression were
detected early in the 7- and 14-day recombinants, but by 42 days
only Foxa1 remained and Foxa2 was almost undetectable. We
also performed IHC with antibodies to both Fox proteins in
native E16, postnatal day 1, and adult mouse bladders. In E16
tissues, Foxa1 was expressed in all urothelium with Foxa2
expression limited to only a few cells. In postnatal day 1 and
adult bladder tissues, Foxa1 was again expressed in all
urothelium but Foxa2 expression was completely undetectable.
These findings illustrate a temporal relationship of Foxa protein
expression patterns that have not been previously reported in the
bladder and it demonstrates the potential power to use this
model not only in studying bladder development but in other
organ systems as well. These findings capture a time period
during development illustrating that Foxa2 is highly expressed
early in bladder progenitor cells, then completely turns off in
mature urothelium. The exact role of the Fox proteins in bladder
development remains unclear, although we have demonstrated a
novel model in which to characterize endodermal related events
involved in bladder embryogenesis.
Overall, developmental models are lacking in which to study
embryonic differentiation into a specific organ. We have shown
that mouse ES cells, in the appropriate inductive signaling
environment, can undergo endodermal lineage transformation
into mature urothelium. Our model yields a powerful example
of the temporal and spatial events occurring during endodermal
differentiation of the bladder. These findings suggest that
ES cells can be controlled to differentiate into specific organsopening up the opportunity to characterize the molecular and
cellular events that give rise to organ stem cells.
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